Identification of Thr 283 as a key determinant of P2X 7 receptor function

British Journal of Pharmacology

Volumn 149, Issue 3, 2006, Pages 261-268

  Young, M T ^a,b   Pelegrin, P ^a   Surprenant, A ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Biotinylation; Dye uptake; Ion channel; Mutagenesis; Patch clamp; Purine receptor

Indexed keywords

ALANINE; CALCIUM; COMPLEMENTARY DNA; ETHIDIUM; ION CHANNEL; METHIONINE; PHENYLALANINE; PURINE P2X7 RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; THREONINE; ADENOSINE TRIPHOSPHATE; PURINE P2 RECEPTOR;

ANIMAL CELL; ARTICLE; CELL STRAIN HEK293; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; FLUORESCENCE; GENE MUTATION; HUMAN; HUMAN CELL; MEMBRANE CURRENT; MICROGLIA; MOLECULAR CLONING; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; WILD TYPE; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMISTRY; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CALCIUM; CELLS, CULTURED; HUMANS; MICE; MICE, INBRED C57BL; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; THREONINE;

EID: 33749019111     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706880     Document Type: Article

References (42)

1. 7 receptors. J Biol Chem 278: 37344-37351.
2. 7 receptor. J Immunol 169: 4108-4112.
3. 7 receptor antagonists. Bioorg Med Chem Lett 13: 4043-4046.
4. 7 receptor antagonists. Bioorg Med Chem Lett 13: 4047-4050.
5. Bianchi BR, Lynch KJ, Touma E, Niforatos W, Burgard EC, Alexander KM et al. (1999). Pharmacological characterization of recombinant human and rat P2X receptor subtypes. Eur J Pharmacol 376: 127-138.
6. 7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114: 386-396.
7. 7 purinoceptor in mouse NTW8 microglial cells. Br J Pharmacol 121: 1429-1437.
8. 7 receptor. Br J Pharmacol 124: 1314-1320.
9. 7 receptor. FEBS Lett 439: 26-30.
10. Di Virgilio F, Borea PA, Illes P (2001). P2 receptors meet the immune system. Trends Pharmacol Sci 22: 5-7.
11. 7R)-induced pore formation in human THP-1 cells. J Pharmacol Exp Ther 308: 1053-1061.
12. Elliott JI, Surprenant A, Marelli-Berg FM, Cooper JC, Cassady-Cain RL, Wooding C et al. (2005). Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes. Nat Cell Biol 7: 808-816.
13. 7 receptor? Am J Physiol Cell Physiol 288: C260-C271.
14. 7 receptor expression after ischemia in the cerebral cortex of rats. J Neuropathol Exp Neurol 63: 686-699.
15. 2 receptor channel. J Physiol 558: 31-43.
16. 7 receptors. Am J Physiol Cell Physiol 279: C1189-C1197.
17. Guerra AN, Fisette PL, Pfeiffer ZA, Quinchia-Rios BH, Prabhu U, Aga M et al. (2003). Purinergic receptor regulation of LPS-induced signaling and pathophysiology. J Endotoxin Res 9: 256-263.
18. 7 receptors. Br J Pharmacol 130: 167-173.
19. 7 receptors. Naunyn Schmiedebergs Arch Pharmacol 363: 639-648.
20. 7 nucleotide receptor: high selectivity for the human versus rat receptor homologues. Mol Pharmacol 54: 22-32.
21. 7 receptors. Am J Physiol Cell Physiol 289: C1295-C1302.
22. 7 receptor signalling complex. EMBO J 20: 6347-6358.
23. 7 receptor alters leukocyte function and attenuates an inflammatory response. J Immunol 168: 6436-6445.
24. Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
25. 7-mediated cell death via a caspase-1-dependent mechanism, independently of cytokine production. J Biol Chem 277: 3210-3218.
26. 7 receptors in ischemic and excitotoxic brain injury in vivo. J Cereb Blood Flow Metab 23: 381-384.
27. MacKenzie A, Wilson HL, Kiss-Toth E, Dower SK, North RA, Surprenant A (2001). Rapid secretion of interleukin-1β by microvesicle shedding. Immunity 15: 825-835.
28. 7 receptors. J Biol Chem 280: 33968-33976.
29. North RA (2002). Molecular physiology of P2X receptors. Physiol Rev 82: 1013-1067.
30. 7 mediates actin reorganization and membrane blebbing in RAW 264.7 macrophages via p38 MAP kinase and Rho. J Leukocyte Biol 75: 1173-1182.
31. Rothwell N (2003). Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential. Brain Behav Immun 17: 152-157.
32. 7-independent mechanism. J Immunol 163: 558-561.
33. 7 receptors. J Biol Chem 276: 125-132.
34. 7 nucleotide receptor mediation of membrane pore formation and superoxide generation in human promyelocytes and neutrophils. J Immunol 166: 6754-6763.
35. 7). Science 272: 735-738.
36. Urban A, Neukirchen S, Jaeger KE (1997). A rapid and efficient method for site-directed mutagenesis using one-step overlap extension PCR. Nucleic Acids Res 25: 2227-2228.
37. 7 receptor-dependent blebbing and the activation of Rho-effector kinases, caspases, and IL-1 beta release. J Immunol 170: 5728-5738.
38. Vial C, Roberts JA, Evans RJ (2004). Molecular properties of ATP-gated P2X receptor ion channels. Trends Pharmacol Sci 25: 487-493.
39. 7 receptor. Neuropharmacology 36: 1285-1294.
40. 7 receptor. J Physiol 519 (Part 2), 335-346.
41. Virginio C, MacKenzie A, Rassendren FA, North RA, Surprenant A (1999b). Pore dilation of neuronal P2X receptor channels. Nat Neurosci 2: 315-321.
42. 7 receptor C terminus. J Biol Chem 277: 34017-34023.